SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-209517
Filing Date
2015-06-02
Accepted
2015-06-01 18:37:38
Documents
8
Period of Report
2015-05-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d930317d8k.htm 8-K 17039
2 EX-10.1 d930317dex101.htm EX-10.1 445642
3 GRAPHIC g930317001.jpg GRAPHIC 93272
4 GRAPHIC g930317002.jpg GRAPHIC 186757
5 GRAPHIC g93031730.jpg GRAPHIC 139195
6 GRAPHIC g930317400.jpg GRAPHIC 151956
7 GRAPHIC g930317image1.jpg GRAPHIC 90821
8 GRAPHIC g930317image2.jpg GRAPHIC 72745
  Complete submission text file 0001193125-15-209517.txt   1477157
Mailing Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421
Business Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421 781-676-2100
INOTEK PHARMACEUTICALS CORP (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36829 | Film No.: 15904852
SIC: 2834 Pharmaceutical Preparations